Lactate Dehydrogenase 5 Expression in Non-Hodgkin Lymphoma Is Associated with the Induced Hypoxia Regulated Protein and Poor Prognosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lactate Dehydrogenase 5 Expression in Non-Hodgkin Lymphoma Is Associated with the Induced Hypoxia Regulated Protein and Poor Prognosis
Authors
Keywords
Cytoplasmic staining, Lymphomas, Cell staining, Negative staining, Nuclear staining, Cancer detection and diagnosis, Prognosis, Pyruvate
Journal
PLoS One
Volume 8, Issue 9, Pages e74853
Publisher
Public Library of Science (PLoS)
Online
2013-09-24
DOI
10.1371/journal.pone.0074853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting homologous recombination and telomerase in Barrett’s adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth
- (2013) R Lu et al. ONCOGENE
- The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo
- (2012) Renquan Lu et al. BMC CANCER
- The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
- (2012) L C J Baker et al. BRITISH JOURNAL OF CANCER
- The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer
- (2012) Alexandra Giatromanolaki et al. CANCER BIOLOGY & THERAPY
- Systematic, evidence-based discovery of biomarkers at the NCI
- (2012) John R. Prensner et al. CLINICAL & EXPERIMENTAL METASTASIS
- Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
- (2012) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5
- (2011) Carlotta Granchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer
- (2011) Renquan Lu et al. BMC CANCER
- Metabolic Imaging: A Link between Lactate Dehydrogenase A, Lactate, and Tumor Phenotype
- (2011) I. Serganova et al. CLINICAL CANCER RESEARCH
- Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment
- (2011) Yanique I. Rattigan et al. EXPERIMENTAL CELL RESEARCH
- LDH-A influences hypoxia-inducible factor 1α (HIF1 α) and is critical for growth of HT29 colon carcinoma cells in vivo
- (2011) Stefan Langhammer et al. Targeted Oncology
- Lactate-Dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1
- (2010) Gian Kayser et al. Diagnostic Pathology
- Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins
- (2009) Liqing Zhuang et al. MODERN PATHOLOGY
- Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
- (2009) Olivier Feron RADIOTHERAPY AND ONCOLOGY
- Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins
- (2008) Alexandra Giatromanolaki et al. LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started